ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

Drug Manufacturers - Specialty & Generic

Healthcare
$71.47 -1.76%

-$1.42 today

Market cap
$1.62B
Beta
0.44
P/E (TTM)
18.5
EPS (TTM)
$4.29
52W Low $62.61High $99.50

Volume 0.29M

Average 0.35M

ANIP Pre-Tax Margin

Income before tax as a percentage of revenue.

ANI Pharmaceuticals, Inc.NASDAQ: ANIP

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin widens to 16.9%

Pre-tax margin was 16.9% in Q1 FY2026, up 6.8 pp from a year earlier. On a trailing-twelve-month basis it was 12.6%, up 16.6 pp year over year. Over 3 fiscal years it widened by 30.7 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
16.9%+4.2 pp QoQ
Last fiscal yearDec 2025
10.8%+14.5 pp YoY
LTMMar 2026
12.6%+16.6 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+6.8 pp——
1 year+14.5 pp——
3 years+30.7 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
10.8%
Year-over-year change
+14.5pp

Pre-Tax Margin vs competitors

How ANIP compares with its peers on the latest reported figures

  • ANIP's LTM Mar 2026 pre-tax margin of 12.6% is the 3rd highest of the 11 companies compared; the peer median is 0.0%.
  • Its year-over-year change of +16.6 pp is the 2nd highest of 10, against a peer median of +3.8 pp.
  • Over three fiscal years its change of +30.7 pp compares with a peer median of +10.2 pp.
ANIP Competitors Peer median
Pre-Tax Margin for ANIP and competitors
Company Period LTM level YoY 3-year change
AMPHAmphastar Pharmaceuticals, Inc.LTM Mar 202614.3% -9.5 pp-5.8 pp
COLLCollegium Pharmaceutical, Inc.LTM Mar 202613.6% +3.8 pp+18.1 pp
ANIPANI Pharmaceuticals, Inc.LTM Mar 202612.6% +16.6 pp+30.7 pp
RDYDr. Reddy's Laboratories LimitedLTM Sep 202610.6% -11.6 pp-8.2 pp
AMRXAmneal Pharmaceuticals, Inc.LTM Jun 20266.5% +3.3 pp+15.8 pp
TEVATeva Pharmaceutical Industries LimitedLTM Jun 20264.2% +4.6 pp+28.2 pp
HROWHarrow Health, Inc.LTM Mar 2026-4.2% +6.0 pp+15.2 pp
VTRSViatris Inc.LTM Jun 2026-4.5% +22.1 pp-42.9 pp
BHCBausch Health Companies Inc.LTM Jun 2026-6.7% -9.6 pp+5.2 pp
EOLSEvolus, Inc.LTM Mar 2026-14.1% +6.0 pp+32.9 pp
LFCRLifecore Biomedical, Inc.LTM Mar 2026-24.9% —-11.4 pp
Peer median (excluding ANIP) 0.0%+3.8 pp+10.2 pp

Competitors are the stored peer set for ANIP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue216.14M316.39M486.82M614.38M883.37M
Cost of Revenue100.61M138.79M181.51M250.21M432.73M
Gross Profit115.53M177.6M305.3M364.17M450.64M
Gross Margin53.5%56.1%62.7%59.3%51.0%
Research & Development11.37M22.32M34.29M44.58M51.66M
Selling, General & Admin84.29M124.04M161.7M249.64M317.75M
Operating Expenses155.32M212.88M258.33M363.58M369.41M
Depreciation & Amortization47.25M59.65M59.79M67.73M91.42M
EBITDA3.12M25.04M106.6M63.12M207.27M
EBITDA Margin1.4%7.9%21.9%10.3%23.5%
Operating Income(39.79M)(35.28M)46.97M584K81.23M
Operating Margin-18.4%-11.2%9.6%0.1%9.2%
Interest Income00000
Interest Expense11.92M28.05M26.94M17.6M20.06M
Other Income / Expenses(16.27M)(27.38M)(27.1M)(22.8M)14.56M
Income Before Tax(56.06M)(62.67M)19.87M(22.21M)95.79M
Pre-Tax Margin-25.9%-19.8%4.1%-3.6%10.8%
Income Tax Expense(13.46M)(14.77M)1.09M(3.69M)17.45M
Net Income(42.6M)(47.9M)18.78M(18.52M)78.34M
Net Margin-19.7%-15.1%3.9%-3.0%8.9%
EPS (Basic)(3.40)(3.05)0.95(1.04)3.50
EPS (Diluted)(3.40)(3.05)0.94(1.04)3.32
Weighted Avg Shares12.6M16.26M18M19.32M20.05M
Weighted Avg Shares (Diluted)12.6M16.26M18.19M19.32M21.23M

ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

Intrinsic Alpha fair value

Locked

Current Price

$71.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.